GERN logo

Geron (GERN) Company Overview

Profile

Full Name:

Geron Corporation

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

July 31, 1996

Indexes:

Not included

Description:

Geron Corporation (GERN) is a biotechnology company focused on developing innovative therapies for cancer. Their main product, imetelstat, targets cancer stem cells to treat hematologic malignancies. Geron aims to improve patient outcomes through advanced research and clinical trials in the field of oncology.

Key Details

Price

$1.73

Annual Revenue

$76.99 M(+32386.92% YoY)

Annual EPS

-$0.27(+15.62% YoY)

Annual ROE

-66.09%

Beta

0.26

Events Calendar

Earnings

Next earnings date:

May 2, 2025

Recent quarterly earnings:

Feb 26, 2025

Recent annual earnings:

Feb 26, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jul 22, 2014

Analyst ratings

Recent major analysts updates

Feb 27, 25 Stifel
Buy
Feb 27, 25 Scotiabank
Sector Outperform
Feb 27, 25 Needham
Buy
Feb 27, 25 Barclays
Overweight
Feb 26, 25 HC Wainwright & Co.
Neutral
Feb 18, 25 B. Riley Securities
Buy
Jan 13, 25 Needham
Buy
Dec 13, 24 Needham
Buy
Dec 10, 24 HC Wainwright & Co.
Buy
Nov 6, 24 HC Wainwright & Co.
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Geron?
  • Does Geron pay dividends?
  • What sector is Geron in?
  • What industry is Geron in?
  • What country is Geron based in?
  • When did Geron go public?
  • Is Geron in the S&P 500?
  • Is Geron in the NASDAQ 100?
  • Is Geron in the Dow Jones?
  • When was Geron's last earnings report?
  • When does Geron report earnings?
  • Should I buy Geron stock now?

What is the ticker symbol for Geron?

The ticker symbol for Geron is NASDAQ:GERN

Does Geron pay dividends?

No, Geron does not pay dividends

What sector is Geron in?

Geron is in the Healthcare sector

What industry is Geron in?

Geron is in the Biotechnology industry

What country is Geron based in?

Geron is headquartered in United States

When did Geron go public?

Geron's initial public offering (IPO) was on July 31, 1996

Is Geron in the S&P 500?

No, Geron is not included in the S&P 500 index

Is Geron in the NASDAQ 100?

No, Geron is not included in the NASDAQ 100 index

Is Geron in the Dow Jones?

No, Geron is not included in the Dow Jones index

When was Geron's last earnings report?

Geron's most recent earnings report was on Feb 26, 2025

When does Geron report earnings?

The next expected earnings date for Geron is May 2, 2025

Should I buy Geron stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions